Peptides
CJC-1295 without DAC
CJC-1295 is a tetrasubstituted 30-amino acid peptide hormone, primarily functioning as a growth hormone releasing hormone (GHRH) analog.
- Selected package
- 2 mg
- CAS number
- 863288-34-0
- Form
- Lyophilised powder
- Storage
- Store lyophilized at −20 °C, dry and protected from light.
No online ordering — send an enquiry and we reply by e-mail. Verify a packaging code
Specifications
- Package sizes
- 2 mg · 5 mg · 10 mg
- CAS number
- 863288-34-0
- Storage
- Store lyophilized at −20 °C, dry and protected from light. Follow the batch-specific label and Certificate of Analysis for validated storage and stability conditions.
- Form
- Lyophilised powder
- Intended use
- This product is intended exclusively for laboratory and scientific research. Not for human or veterinary use.
Package size describes the contents of the vial, not a dose. Batch-specific details are given on the label and the Certificate of Analysis.
About CJC-1295 without DAC
It was invented by ConjuChem, a Canadian biotechnology company.
Modified GRF(1-29) is a Long acting GHRH analog.
Growth-hormone-releasing hormone (GHRH), also known as growth-hormone-releasing factor (GRF or GHRF) or somatocrinin, is a 44-amino acid peptide hormone produced in the hypothalamus by the arcuate nucleus.
Modified GRF(1-29) is a synthetic modification of growth hormone releasing factor (GRF) with D-Ala, Gln, Ala, and Leu substitutions at positions 2, 8, 15, and 27 respectively.
Documentation
Batch documentation is not published online yet. Use “Request Certificate of Analysis”, or read about our quality and documentation.
CJC-1295 without DAC2 mg
Related products
CJC-1295 without DAC + Ipamorelin Research Blend
CJC-1295 without DAC 5 mg + Ipamorelin 5 mg
- CAS number
- 863288-34-0, 170851-70-4
